Allmed Medical Products Co.,Ltd (SHE:002950)
China · Delayed Price · Currency is CNY 9.22
+0.11 (1.21%)
Jul 31, 2026, 3:05 PM CST
SHE:002950 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,809 | 3,672 | 3,326 | 2,757 | 4,211 | 2,926 |
Revenue Growth | 14.09% | 10.38% | 20.66% | -34.53% | 43.92% | -23.70% |
Gross Profit Gross Profit Growth | 1,126 | 1,065 | 928.04 | 657.93 | 1,399 | 872.17 |
Operating Income Operating Income Growth | 611.5 | 572.63 | 433.64 | 179.42 | 816.21 | 387.65 |
Net Income Net Income Growth | 271.33 | 248.88 | 368.68 | 110.4 | 406.79 | 431.21 |
Earnings Per Share EPS Growth | 0.44 | 0.40 | 0.59 | 0.17 | 0.64 | 0.68 |
EPS Growth | -23.61% | -31.82% | 238.44% | -72.87% | -5.82% | -62.73% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Surgery and Wound Care Surgery and Wound Care Growth | 2,847 | 2,664 | 2,178 | 2,626 | 2,190 |
Infection Protection Infection Protection Growth | 195.48 | 196.9 | 231.11 | 1,261 | 433.56 |
Advanced Dressing Advanced Dressing Growth | 151.55 | 102.57 | 61.59 | 58.2 | 30.2 |
Health Care Health Care Growth | 189.32 | 170.93 | 130.69 | 99.72 | 66.89 |
Other Other Growth | 287.84 | 191.57 | 155.23 | 165.68 | 204.71 |
Total Total Growth | 3,672 | 3,326 | 2,757 | 4,211 | 2,926 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 770.06 | 972.18 | 668.32 | 496 | 786.84 | 686.6 |
Total Debt Total Debt Growth | 1,024 | 807.57 | 660.7 | 961.06 | 938.13 | 1,289 |
Net Cash (Debt) Net Cash Growth | -254.34 | 164.61 | 7.62 | -465.06 | -151.29 | -602.53 |
Net Cash Growth | - | 2060.49% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.41 | 0.27 | 0.01 | -0.73 | -0.24 | -0.95 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 572.63 | 717.13 | 711.64 | 423.5 | 1,150 | 374.85 |
Capital Expenditures CapEx Growth | -286.8 | -260.32 | -157 | -286.48 | -398.05 | -290.7 |
Free Cash Flow Free Cash Flow Growth | 285.83 | 456.81 | 554.64 | 137.02 | 751.68 | 84.16 |
Free Cash Flow Growth | -49.28% | -17.64% | 304.78% | -81.77% | 793.19% | -92.95% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 29.57% | 29.01% | 27.90% | 23.87% | 33.22% | 29.81% |
Operating Margin | 16.05% | 15.60% | 13.04% | 6.51% | 19.38% | 13.25% |
Pretax Margin | 8.64% | 8.42% | 13.66% | 6.13% | 11.52% | 17.28% |
Profit Margin | 7.12% | 6.78% | 11.08% | 4.00% | 9.66% | 14.74% |
FCF Margin | 7.50% | 12.44% | 16.68% | 4.97% | 17.85% | 2.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.146 | 0.146 | 0.060 | 0.027 | 0.060 | 0.210 |
Dividend Per Share Growth | 143.33% | 143.33% | 122.22% | -55.00% | -71.43% | -76.14% |
Dividend Yield | 1.58% | 1.36% | 0.70% | 0.29% | 0.51% | 1.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 20.88 | 27.15 | 14.70 | 54.38 | 19.07 | 24.01 |
Forward PE | - | 10.45 | 10.45 | 10.45 | 10.45 | 10.45 |
P/FCF Ratio | 19.85 | 14.79 | 9.77 | 43.81 | 10.32 | 123.03 |
PS Ratio | 1.49 | 1.84 | 1.63 | 2.18 | 1.84 | 3.54 |